Peripheral blood mononuclear cell therapy in PAD patients with intermittent claudication randamized trial

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2006
INTERVENTION: PB‐MNC implantation Saline CONDITION: ASO/Buerger disease PRIMARY OUTCOME: Maximum walking distance, Pain‐free walking distance, Recovery time of lower leg BP after exercise, ABPI at 6 months after treatment as compared with those before treatment SECONDARY OUTCOME: Laser doppler image, Scintigraphy, MRI, Angiography, QOL estimation INCLUSION CRITERIA: PAD patients presenting with severe IC resistant to conventional therapies
Epistemonikos ID: 83ac8e050d145f8fcf500370c04ae3d53fe78b02
First added on: Aug 21, 2024